Cardiovascular risk assessment using ASCVD risk score in fibromyalgia: a single-centre, retrospective study using “traditional” case control methodology and “novel” machine learning

Table 3 ASCVD risk scores stratified for FM disease severity and duration

ASCVD, atherosclerotic cardiovascular disease; FM, fibromyalgia
^†p-value was calculated using Pearson Chi-square and Fisher’s exact test, a value of < 0.05 was considered significant
^§FM disease severity defined by revised fibromyalgia impact questionnaire (FIQR); FIQR score > 60 was considered severe FM and FIQR score ≤ 60 considered mild-moderate FM

ISSN: 2523-3106